Janux Therapeutics competitorsClear all
Janux Therapeutics's top competitors include Numab, Cybrexa Therapeutics, OncoTherapy Science and CARsgen Therapeutics.
 Janux Therapeutics Janux Therapeutics is a biopharmaceutical company developing therapeutics to treat patients with cancer. |  OncoTherapy Science OncoTherapy Science is a company engaged in research and development of cancer therapeutics. |  CARsgen Therapeutics CARsgen Therapeutics is a clinical-stage immune-oncology company that develops a new chimeric T-cell antigen receptor for liver, lung, stomach and brain cancers treatment. | |||
Founding Date | Founding Date 2017 | Founding Date 2011 | Founding Date 2016 | Founding Date 2001 | Founding Date 2014 |
Type | Type Public | Type Private | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Wädenswil, CH HQ | Locations New Haven, US HQ | Locations Kawasaki, JP HQ | Locations Shanghai, CN HQ Beijing, CN Shanghai, CN Shanghai, CN Bellaire, US |
Employees | Employees 20 | Employees 585% increase | Employees 1910% decrease | Employees 66 | Employees 1106% increase |
Valuation ($) | Valuation ($) 430.7 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 97.8 m | Valuation ($) N/A |
Twitter followers | Twitter followers N/A | Twitter followers 124 | Twitter followers 160 | Twitter followers N/A | Twitter followers 100 |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 15 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 1 |
Alexa Website Rank | Alexa Website Rank 816802 | Alexa Website Rank 909068 | Alexa Website Rank 494179 | Alexa Website Rank N/A | Alexa Website Rank 527228 |
Employee Rating | Employee Rating N/A | Employee Rating N/A | Employee Rating N/A | Employee Rating N/A | Employee Rating N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 110m (about 1 year ago) | Latest funding round $ 25m (about 1 year ago) | Latest funding round N/A | Latest funding round $ 186m (over 1 year ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 132.3m | Total funding raised $ 44.4m | Total funding raised N/A | Total funding raised $ 276m |
For sources of this data, please see the company profile
View company profiles
Numab
HQ
Wädenswil, CH
Employees
58↑ 5% increase
Numab Therapeutics is an oncology-focused biopharmaceutical company.
View company
Cybrexa Therapeutics
HQ
New Haven, US
Employees
19↓ 10% decrease
Cybrexa Therapeutics is a biotechnology company developing cancer therapeutics.
View companyOncoTherapy Science
HQ
Kawasaki, JP
Employees
66
OncoTherapy Science is a company engaged in research and development of cancer therapeutics.
View companyCARsgen Therapeutics
HQ
Shanghai, CN
Employees
110↑ 6% increase
CARsgen Therapeutics is a clinical-stage immune-oncology company that develops a new chimeric T-cell antigen receptor for liver, lung, stomach and brain cancers treatment.
View company